Unknown

Dataset Information

0

Vendor effects on murine gut microbiota and its influence on lipopolysaccharide-induced lung inflammation and Gram-negative pneumonia.


ABSTRACT: BACKGROUND:The microbiome has emerged as an important player in the pathophysiology of a whole spectrum of diseases that affect the critically ill. We hypothesized that differences in microbiota composition across vendors can influence murine models of pulmonary lipopolysaccharide (LPS) inflammation and Gram-negative pneumonia. METHODS:A multi-vendor approach was used with genetically similar mice derived from three different vendors (Janvier, Envigo, Charles River). This model was employed to study the effect on the host response to a pulmonary LPS challenge (1 ?g Klebsiella pneumoniae LPS, intranasal), as well as experimental K. pneumoniae infection (ATCC43816, 1 × 104 CFU, intranasal). RESULTS:Gut microbiota analysis revealed profound intervendor differences in bacterial composition as shown by beta diversity and at various taxonomic levels. Tumor necrosis factor (TNF)-? and interleukin (IL)-6 release in lung and bronchoalveolar lavage fluid (BALF) were determined 6 and 24 h after intranasal treatment with LPS. No differences were found between the groups, with the exception for Envigo, showing a higher level of TNF? in lung and BALF at 6 h compared to Janvier and Charles River. In another set of experiments, mice from different vendors were subjected to a clinically relevant model of Gram-negative pneumonia (K. pneumoniae). At 12 and 36 h post-infection, no intervendor differences were found in bacterial dissemination, or TNF? and IL-6 levels in the lungs. In line, markers for organ failure did not differ between groups. CONCLUSIONS:Although there was a marked variation in the gut microbiota composition of mice from different vendors, the hypothesized impact on our models of pulmonary inflammation and severe pneumonia was limited. This is of significance for experimental settings, showing that differences in gut microbiota do not have to lead to differences in outcome.

SUBMITTER: Wolff NS 

PROVIDER: S-EPMC7447702 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vendor effects on murine gut microbiota and its influence on lipopolysaccharide-induced lung inflammation and Gram-negative pneumonia.

Wolff Nora S NS   Jacobs Max C MC   Haak Bastiaan W BW   Roelofs Joris J T H JJTH   de Vos Alex F AF   Hugenholtz Floor F   Wiersinga W Joost WJ  

Intensive care medicine experimental 20200825 1


<h4>Background</h4>The microbiome has emerged as an important player in the pathophysiology of a whole spectrum of diseases that affect the critically ill. We hypothesized that differences in microbiota composition across vendors can influence murine models of pulmonary lipopolysaccharide (LPS) inflammation and Gram-negative pneumonia.<h4>Methods</h4>A multi-vendor approach was used with genetically similar mice derived from three different vendors (Janvier, Envigo, Charles River). This model wa  ...[more]

Similar Datasets

| S-EPMC8272965 | biostudies-literature
| S-EPMC3811629 | biostudies-literature
| S-EPMC6824972 | biostudies-literature
| S-EPMC4855262 | biostudies-other
| S-EPMC4823881 | biostudies-literature
| S-EPMC4715324 | biostudies-literature
| S-EPMC8053950 | biostudies-literature